All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
X-Chem Inc., of Waltham, Mass., said it achieved several milestones in a licensing agreement with Astrazeneca plc, of London, established in May 2012. That deal garnered the company an up-front payment and research funding, as well as discovery and clinical development milestones.